NN6 logo

NanoRepro AG Stock Price

XTRA:NN6 Community·€19.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

NN6 Share Price Performance

€1.55
0.26 (20.23%)
€1.55
0.26 (20.23%)
Price €1.55

NN6 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and good value.

2 Risks
2 Rewards

NanoRepro AG Key Details

€5.2m

Revenue

€2.1m

Cost of Revenue

€3.0m

Gross Profit

€4.8m

Other Expenses

-€1.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.14
58.90%
-33.37%
0%
View Full Analysis

About NN6

Founded
n/a
Employees
21
CEO
Lisa Jungst
WebsiteView website
www.nanorepro.com

NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preventive healthcare line products. The company also develops and commercializes immunochromatographic lateral flow tests; and tests for hospitals and medical practices. The company is headquartered in Marburg, Germany.

Recent NN6 News & Updates

Recent updates

No updates